Paolo Cravedi, MD

Paolo Cravedi, MD, PhD, is Professor of Medicine in the Division of Nephrology and the Director of the Translational Transplant Research Center (TTRC). Dr. Cravedi is a scientist physician with a strong interest in kidney transplantation and autoimmune glomerular diseases. His initial studies have contributed to defining the organ allocation system currently used in many countries around the world. Dr. Cravedi was involved in the design and implementation of the first mechanistic clinical studies testing the safety/efficacy profile of B cell depletion in subjects with membranous nephropathy or focal segmental glomerulosclerosis (FSGS).

In 2011, Dr. Cravedi joined Icahn School of Medicine at Mount Sinai, where he started working on the effects of complement and erythropoietin in adaptive immune response. He is interested in implementing new technologies to study alloimmune responses and, more recently, his work has been testing the immune effects of fasting in transplantation.